We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Increase in services provided in 2023 by all sequencing platforms, excluding COVID-related activities Positive EBITDA for the third year running, despite inflation impacting reagent costs SeqOIA...
Significant reduction of COVID-19 related activities Growth of all other lines of business Cash totaling €2.9m on Dec 31st, 2023 Laboratory in Évry accredited by the College of American...
Résilience de la rentabilité malgré le contexte inflationniste Croissance des activités aux laboratoires d’Évry Regulatory News: IntegraGen (FR0010908723 – ALINT – Eligible PEA PME...
Baisse de l’activité de la plateforme de séquençage en microbiologie après une forte contribution enregistrée au 1er semestre 2022 dans le cadre de la pandémie de Covid-19. Retraitée de cet...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.07 | -10.6060606061 | 0.66 | 0.66 | 0.585 | 4891 | 0.61161147 | DE |
4 | -0.12 | -16.9014084507 | 0.71 | 0.86 | 0.585 | 5478 | 0.69489545 | DE |
12 | -0.16 | -21.3333333333 | 0.75 | 0.92 | 0.585 | 5833 | 0.76350089 | DE |
26 | -0.364 | -38.1551362683 | 0.954 | 1.05 | 0.585 | 4104 | 0.79668886 | DE |
52 | -0.685 | -53.7254901961 | 1.275 | 1.57 | 0.585 | 3420 | 1.00810471 | DE |
156 | -1.29 | -68.6170212766 | 1.88 | 2.04 | 0.585 | 5228 | 1.31832747 | DE |
260 | -0.87 | -59.5890410959 | 1.46 | 2.67 | 0.585 | 36153 | 1.66538588 | DE |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions